Jason M. Lappé, MS; Joseph B. Muhlestein, MD; Donald L. Lappé, MD; Rodney S. Badger, MD; Tami L. Bair, BS; Ruth Brockman, RN, MBA; Thomas K. French, MStat; Linda C. Hofmann, MS, BSN; Benjamin D. Horne, MStat, MPH; Susan Kralick-Goldberg, RN, MSN; Nan Nicponski, RN, MBA; Janette A. Orton, RN, MS; Robert R. Pearson, BS; Dale G. Renlund, MD; Holly Rimmasch, RN, MSN; Colleen Roberts, RN, MS; Jeffrey L. Anderson, MD
Acknowledgments: The authors thank Julie Burchell, RN, BSN; Michael Carnley; Dal C. Coleman, RPh; Kim Henrichsen, RN, MS, CCRN; Diane Marshall, MAM; Mikelle D. Moore, MBA, MHSA; Lynn R. Nimer, MD; Katey Roundy; Shane R. Stevenson, BS; Diane S. Wallace, RN, MSN, ANP-C; Sharon L. Watson, RHIT; Marie M. Wright, RN; Scott Yardley, RPh; Michelle LeBaron, RN; Susan E. Pollock, BS; Jeanette Wheeler, RN; and the administrative, cardiovascular nursing, and physician staff of Intermountain Health Care for valuable contributions and assistance.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Joseph B. Muhlestein, MD, LDS Hospital Cardiovascular Department, 8th Avenue and C Street, Salt Lake City, UT 84143.
Current Author Addresses: Mr. Lappé; Drs. Muhlestein, Lappé, Badger, Renlund, and Anderson; Ms. Bair; Ms. Brockman; Mr. French; Ms. Hofmann; Mr. Horne; Ms. Kralick-Goldberg; Ms. Nicponski; Ms. Orton; Mr. Pearson; Ms. Rimmasch; and Ms. Roberts: LDS Hospital Cardiovascular Department, 8th Avenue and C Street, Salt Lake City, UT 84143.
Lappé J., Muhlestein J., Lappé D., Badger R., Bair T., Brockman R., French T., Hofmann L., Horne B., Kralick-Goldberg S., Nicponski N., Orton J., Pearson R., Renlund D., Rimmasch H., Roberts C., Anderson J.; Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program. Ann Intern Med. 2004;141:446-453. doi: 10.7326/0003-4819-141-6-200409210-00010
Download citation file:
Published: Ann Intern Med. 2004;141(6):446-453.
Despite evidence to support the effectiveness of a variety of interventions for the secondary prevention of cardiovascular disease, many eligible patients do not receive these interventions.
Compared with a baseline period, patients hospitalized with cardiovascular disease who received an intervention that focused on discharge medications had higher rates of prescription of aspirin, β-blockers, statins, angiotensin-converting enzyme inhibitors, and warfarin at hospital discharge. The risk for death and readmission was lower in the intervention period than in the baseline period.
The pre–post design of this study does not permit conclusions about a causal relationship between the intervention and the observed improvements.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Hospital Medicine, Prevention/Screening.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only